Please assess the completion status of the following clinical trial:

Trial Title: Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for dental extraction and treated with edoxaban, apixaban, rivaroxaban or dabigatran~* Not having taken the direct oral anticoagulant on the day of the extraction~* Provision of signed and dated informed consent form~* Stated willingness to comply with all study procedures and availability for the duration of the study~Exclusion Criteria:~* Subjects with any condition that as judged by the Investigator would place the subject at increased risk of harm if he/she participated in the study.~* Pregnancy or lactation~* Known allergic reaction to tranexamic acid

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: PLACEBO_COMPARATOR): 10mL water as mouthwash with white cherry flavor in oral syringes. Once before tooth extraction and 3 times daily during 3 days post-extraction (starting day after extraction).
- Tranexamic Acid Group (Type: EXPERIMENTAL): 10mL tranexamic acid mouthwash 10% in oral syringes. Once before tooth extraction and 3 times daily during 3 days post-extraction (starting day after extraction).

Based on this trial design, predict the completion outcome and termination type (if applicable).